title: Infected Cardiac Myxoma: an Updated Review.
abstract: OBJECTIVE
  This study aims to present an updated clinical picture of the infected cardiac myxoma. Revankar & Clark made a systematic review of infected cardiac myxoma based on the literature before 1998. Since then, there has not been any updated information describing its recent changing trends.
  
  
  METHODS
  A comprehensive literature search of infected cardiac myxoma was conducted on MEDLINE, Highwire Press and Google between 1998 and 2014.
  
  
  RESULTS
  In comparison with Revankar & Clark's series, the present series disclosed a significantly decreased overall mortality. It is believed that refinement of the prompt diagnosis and timely management (use of sensitive antibiotics and surgical resection of the infected myxoma) have resulted in better outcomes of such patients.
  
  
  CONCLUSIONS
  The present series of infected cardiac myxoma illustrated some aggravated clinical manifestations (relative more occasions of high-grade fever, multiple embolic events and the presence of refractory microorganisms), which should draw enough attention to careful diagnosis and treatment. In general, the prognosis of infected cardiac myxoma is relatively benign and the long-term survival is always promising.
authors.affiliation: The First Hospital of Putian, Teaching Hospital, Fujian Medical University, Putian, China.
authors.forename: Shi-Min
authors.initials: SM
authors.lastname: Yuan
mesh_terms: D004617:Embolism / Q000209:etiology; D005334:Fever / Q000209:etiology; D006338:Heart Neoplasms / Q000150:complications* / Q000175:diagnosis / Q000601:surgery / Q000628:therapy; D006801:Humans; D009232:Myxoma / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D013290:Streptococcal Infections / Q000150:complications* / Q000175:diagnosis / Q000601:surgery / Q000628:therapy